Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
SCAI 25: Insights from the TRITAVI Registry
Author(s): Francesco Pelliccia Added: 1 year ago
SCAI 2025 - Insights from antiplatelet therapy after transcatheter aortic valve replacement (TAVR) show patients who received single antiplatelet treatment had significantly lower rates of overall six-month mortality, CV death and non-CV death compared to those treated with double antiplatelet treatment.Dr Francesco Pelliccia (Sapienza University of Rome, Rome, IT) joins us to discuss insights… View more

Anticoagulation

Intervention
Left Main Disease: The Last Frontier for Medical Therapy in Stable CAD?
Author(s): Armin Arbab-Zadeh , Michelle Graham , Hector M Garcia-Garcia , et al Added: 8 months ago

Intervention

Prevention & Chronic Conditions
Post-PE Syndrome and Transcatheter Therapy
Author(s): Belén Biscotti Rodil , Juan Duarte Torres , Irene Martín de Miguel , et al Added: 5 months ago

Intervention

Heart Failure
Definitions and Implications of Shock Diagnosis and Therapy with Dr Frederick Welt
Author(s): Frederick Welt Added: 7 months ago
Learn about the definition and implications of a shock diagnosis and systems of care and the role of the shock team from Dr Frederick Welt (University of Utah, US).This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr Frederick… View more

Intervention

MI/ACS
Effectiveness of Hypothermia in PCI for STEMI: A Meta-analysis
Author(s): Mohamed Riad Abouzid , Ibrahim Kamel , Karim Ali , et al Added: 1 month ago

Intervention

MI/ACS
Sex Influences DAPT De-escalation Outcomes Post-PCI
Added: 3 weeks ago Source:  Interventional Cardiology
De-escalation of dual antiplatelet therapy (DAPT) is a strategy used to improve outcomes after percutaneous coronary intervention (PCI).¹˒² However, the impact of patient sex on the safety and efficacy of these strategies has been unclear. A new network meta-analysis published in the European Heart Journal has investigated these potential differences.¹MethodologyThe study analysed data from 20… View more

Intervention

Anticoagulation
LINC 2025: 12-Month Amputation and Readmission Rates from TRUE-PTX
Author(s): Marianne Brodmann Added: 1 year ago
LINC 2025 - 12-month amputation and readmission rates from the TRUE-PTX study suggests endovascular revascularisation for peripheral artery disease (PAD) with drug-eluting devices lead to better outcomes than with bare device therapies.Dr Marianne Brodmann (Medical University of Graz, AT) joins us to discuss the TRUE-PTX study evaluating a database of patients in the US with PAD who have recieved… View more

Intervention

Vascular Disease and Surgery
The Future of Heart Valve Treatment: Proven Therapies and Patient Impact
Author(s): Brian O’Neill, Bryan Zweig, Ryan Gindi Start date: Apr 04, 2025
Join us for an exclusive webinar, part of the Beyond the Heartbeat series, that delves into the latest advancements in mitral and tricuspid regurgitation treatment. Our expert panel will equip you with details related to groundbreaking clinical trial data and practical insights to enhance your professional practice.Learning Objectives:Explore Proven Therapies: Discover recent clinical data from… View more

Intervention

Guidelines & Statements
Evolving Strategies in Pulmonary Embolism: From Risk Stratification to Interventional Therapy
Author(s): Stavros Konstantinides , José M Montero-Cabezas , Mario Iannaccone , et al Added: 5 months ago
This expert-led, on-demand programme explores the latest evidence and interventional strategies for intermediate-high and high-risk pulmonary embolism (PE). Chaired by Prof Stavros Konstantinides (University of Mainz, Mainz, DE) and featuring renowned specialists Dr José Montero-Cabezas (Leiden University Medical Center, Leiden, NL), Dr Mario Iannaccone (Turin Nord Emergency Hospital, Turin, IT)… View more

Intervention
TCT 24: The TRISCEND II Trial
Author(s): Susheel Kodali Added: 1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter tricuspid valve replacement (TTVR) compared to optimal medical therapy for patients with severe tricuspid regurgitation (TR).Dr Susheel Kodali (Columbia University Medical Center, New York, US) joins us onsite at TCT Conference to discuss the findings from the TRISCEND II Trial (NCT04482062; Edwards Lifesciences).TRISCEND II is a… View more

Intervention